Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease
Conditions
- Wet Age-related Macular Degeneration
Interventions
- DRUG: Aflibercept (Eylea, BAY86-5321)
Sponsor
Bayer